Ahead of the UK Food Standards Agency’s 31 March 2021 deadline for CBD products to have a validated novel foods application, the Association for the Cannabinoid Industry (ACI), which works to create a safe, legal and well-regulated CBD market in the UK,...
With the regulatory path forward for hemp-derived CBD in foods and supplements no clearer a year after the FDA’s May 2019 public meeting, trade association The Council for Responsible Nutrition (CRN) has filed a citizen’s petition urging the FDA to regulate...
California-based Alkemist Labs has again achieved accreditation to the requirements of ISO/IEC 17025:2017, but this time the accreditation includes the lab’s internally developed cannabinoids and terpenes assays.
The FDA says it has made “substantial progress” in forging a regulatory path for ingestible CBD products, but has given no indication of when it might provide food and supplement makers with more clarity.
CBD specialist Elixinol Global has managed to hit its capital raising target of AUD$11m (US$7.3m) following a two-stage fund raising exercise, which it believes is a proof of how its CBD supplements have resonated with its investors.
A judge has approved a permanent injunction order against the principals of a dietary supplement company who allegedly repeatedly ignored FDA warnings and inspection findings on illegal disease claims and other violations.
CBD may improve joint pain in canines, an animal model of arthritis deemed appropriate for assessing human arthritis pain, according to a new study. The study authors said follow-up investigations in humans are now warranted.
Several high-profile lawsuits challenging the legal status of CBD products have been stayed (effectively put on ice until the FDA outlines a regulatory path forward for CBD in foods & supplements) or voluntarily dismissed in recent weeks.